NPPA panel fixes retail price of spray containing Diclofenac, Methyl Salicylate, Menthol, Details

Published On 2022-02-11 11:00 GMT   |   Update On 2022-02-11 11:00 GMT

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of Spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceuticals.

The retail price of each of spray containing Diclofenac Diethylamine I P 2.32% w/ w (eq. to Diclofenac Sodium 2% w/w) plus Methyl Salicylate IP 1 0.00 % w/w plus Menthol IP 5.0 % w/w for  Pontika Aerotech  (manufacturer) and lntas Pharmaceuticals (marketer) 
has been set at Rs 2.93 per gm excluding GST.
This recommendation came during the 38th meeting of the 'Multidisciplinary Committee of Experts' meeting, held on January 24, 2022, under the convenorship of Dr. Vinod Kotwal, Member Secretary, through video-conferencing.
The issue of retail price fixation of Spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed Intas Pharmaceutical under Para 5 of DPCO 2013 was analyzed at the meeting.
Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID). NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac Diethylamine is used to relieve pain and inflammation associated with musculoskeletal disorders, strain, sprain, arthritis, and low back pain.

Methyl salicylate is a topical counter-irritant used for the symptomatic relief of acute musculoskeletal pain in the muscles, joints, and tendons. Menthol is an organic compound used to treat mild to moderate muscle and joint pain.

At a recent Multidisciplinary Committee of Experts meeting, the panel noted that the retail price of the subject formulation has been given to various companies and the companies have submitted the form-V data to NPPA.

Based on Form V data the committee decided to recommend the retail price of spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceutical.
Accordingly, the committee recommended the retail price of the spray containing Diclofenac Diethylamine IP 2.32%, Methyl Salicylate IP 10%, Menthol IP 5% manufactured by Pontika Aerotech and marketed by Intas Pharmaceutical at Rs 2.93 per gm excluding GST, 
as detailed below
.

S. No .

Company

Unit

PTR

PTR per gm

1.

M/ s Sun Pharmaceutical Industries Ltd. (as per Form-V data)

55gm

139.29

Rs. 2.53

2.

!Add: Retailer margin @16% (16% ofs l. No. 1 )

Rs. 0.40

3.

Pro posed Retail Price based on submitted Form-V by the companies (excluding GST) (sl. No . 1+ sl. No. 2)

Rs. 2.93 (Retail price per gm ex. GST)

4.

Retail price claimed


Rs. 6.36 per gm excluding GST

5.

Recommended retail price

Rs. 2.93 per gm excluding GST

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News